MSB 2.17% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.